查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1924680

IVIS成像系統市場按產品類型、組件、應用和最終用戶分類 - 全球預測（2026-2032年）

IVIS Imaging Systems Market by Product Type, Component, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年 IVIS 影像系統市場規模為 3.4907 億美元，預計到 2026 年將成長至 3.9216 億美元，年複合成長率為 12.48%，到 2032 年將達到 7.9523 億美元。

關鍵市場統計數據
基準年 2025 3.4907億美元
預計年份：2026年 3.9216億美元
預測年份 2032 7.9523億美元
複合年成長率 (%) 12.48%

一個簡潔的框架，整合了技術進步、科學重點和商業性決策，以指導體內成像的投資和策略。

本執行摘要為相關人員提供了一個聚焦的切入點，幫助他們了解體內影像領域不斷發展的格局。它簡潔地闡述了科學細節與商業性需求之間的關聯。本文件整合了技術進步、應用需求趨勢、供應鏈考量和競爭動態，旨在幫助經營團隊主管制定短期和中期決策。透過重點闡述核心促進因素（儀器創新、軟體分析、耗材生態系統和跨產業應用），本概要揭示了研究重點如何轉化為採購和夥伴關係決策。

儀器進步、探針創新和整合分析技術如何重塑臨床前成像領域的實驗設計、採購重點和服務差異化

生物成像領域正經歷變革性的轉變，這得益於儀器、分子探針化學和計算分析技術的進步。在儀器方面，檢測器靈敏度和動態範圍的提升，以及更穩定、可調諧光源的出現，使得以往需要侵入性技術才能完成的實驗能夠以非侵入性的方式進行，從而加速了臨床前研究流程。同時，探針研發人員在提高亮度和特異性的同時，降低了脫靶訊號，從而提高了縱向研究的可靠性，並拓展了可偵測的終點範圍。只有當這些硬體和試劑的改進與強大的軟體流程相結合時，才能真正發揮其潛力。這些軟體流程能夠自動進行影像分析，校正多波長頻譜，並將縱向資料集整合為可解釋的生物標記。

評估關稅引發的供應鏈重組、零件採購變化和採購調整對生物醫學影像生態系統的整體影響

美國加強貿易措施和調整關稅對生物成像系統及其供應鏈產生了複雜的影響。影響光學元件、半導體檢測器和精密機械組件的關稅提高了某些進口子組件的到岸成本，促使製造商重新評估籌資策略。對於光電倍增管、雷射二極體和某些高性能光學元件等供應商高度集中的產品，關稅可能會造成短期採購壓力，進而影響前置作業時間和資本規劃。為因應這種情況，企業通常採用近岸外包、供應商多元化和庫存避險等組合策略，以確保生產的連續性和可預測的交貨時間。

深入的細分洞察，將模態細微差別、特定應用需求、最終用戶採購行為和組件級設計權衡聯繫起來

了解不同產品類型及其對後續實驗的影響至關重要，這有助於將功能與實驗需求相匹配。生物發光成像和螢光成像構成主要的成像模式兩大類，其中生物發光可細分為頻譜發光和標準生物發光。前者能夠實現多重檢測中多種報告分子的頻譜分辨，而後者則是高靈敏度單報告分子研究的主力。螢光成像包括新興螢光技術、頻譜螢光系統和近紅外線螢光模式，每種模式在穿透深度、訊號雜訊比和探針可用性方面各有優劣。這些成像模式的選擇直接影響儀器配置、探針選擇和後續分析流程。

美洲、歐洲、中東和非洲以及亞太地區的區域特定趨勢正在影響招募模式、採購偏好和供應鏈策略。

區域趨勢顯著影響需求模式、監管限制和供應鏈韌性，且這些影響在不同地區差異顯著。在美洲，強大的轉化研究計畫、集中的製藥投資以及資金充足的學術研究中心正在推動先進成像技術的早期應用，並支撐著對整合硬體-軟體-服務組合的需求。該地區還優先考慮對縱向研究和合約研究組織（CRO）夥伴關係的投入，而這些都需要高通量、檢驗的平台。在歐洲、中東和非洲，西歐強大的研究基礎、中東新興的產業叢集以及其他地區波動的資金籌措環境共同造就了該地區的多樣性。法規結構和泛歐合作舉措正在影響標準化和機構間資料共用，從而推動對符合區域隱私法規的互操作系統和雲端資料管理的需求。在亞太地區，生命科學研發的快速擴張、公共和私人對轉化研究基礎設施投資的不斷增加以及蓬勃發展的製造業基礎，共同構成了對價格競爭力和快速創新週期的雙重壓力。綜上所述，這些區域趨勢要求制定差異化的商業策略，根據當地的採購慣例和法規環境調整產品組合、定價模式和服務產品。

技術差異化、整合服務模式和穩健的供應鏈策略如何塑造競爭優勢和客戶維繫的動態

生物成像領域的競爭地位取決於技術領先性、服務生態系和管道能力的綜合考量。成功的公司憑藉其在檢測器靈敏度、光學多功能性和軟體分析方面的卓越性能脫穎而出，並日益整合安裝、檢驗和培訓服務，以降低市場准入門檻。與試劑和探針開發商建立策略聯盟，在硬體銷售和耗材應用之間建立互補關係，有助於確保持續的收入來源。投資於模組化架構和韌體/軟體驅動的功能發布的公司，能夠確保客戶的升級路徑，並延長儀器的使用壽命，這對於資金預算有限的機構而言，無疑是一個極具吸引力的商業性策略。

供應商和機構買家可以採取哪些切實可行的策略步驟來延長成像系統平台的使用壽命、創造經常性收入並增強供應鏈的韌性

產業領導者應優先考慮平台設計的模組化和可升級性，以滿足市場對高效資本獲取模式日益成長的偏好。透過實現檢測器和照明模組的現場可升級，供應商能夠在多年研究專案中維繫客戶關係，避免過早更換設備。同時，投資經過檢驗的軟體流程（例如自動化影像預處理、頻譜分解和時間序列生物標記提取）能夠提升硬體銷售價值，並透過訂閱和授權協議創造持續的商機。這些軟體投資應強調互通性和符合機構資料管治政策，以鼓勵不同終端使用者採用。

本報告的研究採用了嚴謹的混合方法研究途徑，結合了專家訪談、技術文獻綜合、供應鏈映射和情境檢驗，以確保得出可靠的結論。

本報告的研究融合了定性和定量方法，以確保證據基礎的穩健性和可重複性。主要研究包括對設備工程師、學術和工業實驗室的採購主管以及受託研究機構的成像核心主管進行結構化訪談，以了解營運挑戰、升級原因和服務期望。次要研究整合了關於成像模式的同行評審文獻、檢測器和探針專利申請趨勢以及已發布的技術規範，以繪製能力差距圖。供應鏈分析確定了檢測器、光源和光學組件的關鍵上游供應商，並將這些發現與進出口數據和製造地評估結果進行了交叉檢驗。

整合技術、商業性和營運方面的必要因素，將決定哪些組織能夠成功地將成像能力轉化為科學和商業成果。

生物成像系統正處於轉折點，儀器靈敏度、探針化學和計算分析的融合正在拓展實驗能力並加速轉化研究。學術界、合約研究機構 (CRO) 和產業界的相關人員面臨多重壓力：既要保持數據的高品質和可重複性，又要控制供應鏈不確定性下的資本和營運成本，還要最大限度地發揮整合硬體、軟體和服務產品的價值。克服這些挑戰需要重視模組化的產品策略、能夠實現可重複分析的檢驗的軟體生態系統以及具有韌性的供應鏈。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. IVIS影像系統市場依產品類型分類

  • 生物發光成像
    • 頻譜生物發光
    • 標準生物發光
  • 螢光影像

9. IVIS成像系統市場（按組件分類）

  • 消耗品
    • 成像探針
    • 試劑
  • 硬體
    • 成像檢測器
      • 光電倍增管
      • 固體檢測器
    • 光源
      • 雷射二極體
      • LED陣列
    • 光學系統
  • 服務
    • 諮詢和培訓
    • 安裝和維護
  • 軟體
    • 資料管理軟體
    • 影像分析軟體

第10章 IVIS影像系統市場依應用領域分類

  • 心血管調查
    • 缺血研究
    • 血管影像
  • 藥物發現
    • 藥物動力學
    • 目標檢驗
  • 神經科學
    • 神經退化性疾病影像學
    • 神經炎症成像
  • 腫瘤學
    • 轉移監測
    • 治療效果評估
    • 腫瘤檢測
      • 早期腫瘤檢測
      • 晚期腫瘤檢測

第11章 依最終用戶分類的 IVIS 影像系統市場

  • 學術研究機構
  • CRO（受託研究機構）
  • 製藥和生物技術公司

12. 各地區 IVIS 影像系統市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 IVIS影像系統市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國 IVIS 影像系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國IVIS影像系統市場

第16章 中國IVIS影像系統市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies
  • Analytik Jena AG
  • Berthold Technologies GmbH & Co. KG
  • BioTek Instruments, Inc.
  • Bruker Corporation
  • Caliper Life Sciences
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • LI-COR Biosciences
  • Miltenyi Biotec
  • Molecular Devices, LLC
  • Olympus Corporation
  • PerkinElmer Inc.
  • Promega Corporation
  • Siemens Healthineers
  • Spectral Instruments Imaging
  • Thermo Fisher Scientific Inc.
Product Code: MRR-7A380DA7C41E

The IVIS Imaging Systems Market was valued at USD 349.07 million in 2025 and is projected to grow to USD 392.16 million in 2026, with a CAGR of 12.48%, reaching USD 795.23 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 349.07 million
Estimated Year [2026] USD 392.16 million
Forecast Year [2032] USD 795.23 million
CAGR (%) 12.48%

A concise framing that aligns technological evolution, scientific priorities, and commercial decision-making to guide in vivo imaging investments and strategies

This executive summary presents a focused entry point for stakeholders navigating the evolving in vivo imaging landscape, offering a concise orientation that bridges scientific nuance with commercial imperatives. The document synthesizes technological advances, application demand signals, supply-chain considerations, and competitive dynamics to help executives frame short- and medium-term choices. By foregrounding core drivers-instrument innovation, software-enabled analytics, consumable ecosystems, and cross-sector adoption-the narrative underscores the pathways by which research priorities translate into procurement and partnership decisions.

Readers will find context for how imaging modalities and platform architectures influence experimental throughput, data quality, and cost of ownership. The introduction sets expectations for the subsequent sections, highlighting where regulatory shifts, funding cycles, and translational needs converge to create differentiated value. It also explains the analytical lens used across the report: a product- and application-aware approach that connects component-level realities with end-user workflows. Ultimately, this orientation equips R&D leaders, procurement teams, and commercial strategists to prioritize investments, align vendor selection with scientific requirements, and anticipate emerging service needs across academic, contract research, and industry settings.

How instrumentation advances, probe innovation, and integrated analytics are reshaping experimental design, procurement priorities, and service differentiation across preclinical imaging

The in vivo imaging landscape is undergoing transformative shifts driven by converging advances in instrumentation, molecular probe chemistry, and computational analytics. On the instrumentation front, greater sensitivity and dynamic range in detectors-coupled with more stable and tunable light sources-are enabling experiments that once required invasive techniques to be performed noninvasively, thereby accelerating preclinical workflows. Concurrently, probe developers are extending brightness and specificity while reducing off-target signal, which improves longitudinal study fidelity and expands feasible endpoints. These hardware and reagent improvements are only fully realized when paired with robust software pipelines that automate image analysis, correct for multispectral overlap, and integrate longitudinal datasets into interpretable biomarkers.

Beyond the laboratory benchtop, there is a palpable shift in procurement and consumption patterns. Translational researchers and biopharma customers increasingly favor modular, upgradeable platforms that reduce capital replacement cycles while enabling capability add-ons such as multispectral imaging or near-infrared channels. Contract research organizations and academic consortia demand interoperable systems that support standardized protocols and reproducible outputs. At the same time, services adjacent to hardware-training, installation, and image analysis consulting-are becoming essential differentiators. These trends collectively reconfigure value propositions across the ecosystem, privileging manufacturers and service providers who can deliver integrated, validated workflows that reduce time to actionable experimental results.

Assessment of how tariff-driven supply chain reconfiguration, component sourcing shifts, and procurement adjustments collectively influence the in vivo imaging ecosystem

The introduction of elevated trade measures and tariff realignments from the United States has complex implications for in vivo imaging systems and their supply chains. Tariffs that affect optical components, semiconductor detectors, and precision mechanical assemblies increase landed costs for certain imported subcomponents, prompting manufacturers to reassess sourcing strategies. Given the concentration of specialized suppliers for items such as photon multiplier tubes, laser diodes, and certain high-spec optics, tariffs can create acute short-term procurement pressures that ripple through lead times and capital planning cycles. In response, firms often adopt a mix of nearshoring, supplier diversification, and inventory hedging to preserve production continuity and maintain predictable delivery schedules.

These adjustments in supplier networks also alter product roadmaps, as companies may prioritize designs that reduce reliance on tariff-affected parts by modularizing affected subsystems or by substituting components where performance trade-offs are acceptable. For end users, the resultant cost inflation on hardware and consumables can shift purchasing behavior toward refurbished systems, multi-year service agreements, or cloud-based analysis subscriptions that decouple capital expenditure from capability access. Additionally, research institutions with constrained budgets may adjust study designs to prioritize longitudinal imaging on established platforms rather than investing in incremental hardware upgrades. In a broader sense, elevated trade frictions accelerate consolidation among suppliers who can absorb tariff-related cost increases, while incentivizing localized manufacturing investments in critical upstream components to reduce vulnerability to cross-border policy volatility.

Deep segmentation intelligence linking modality nuances, application-specific requirements, end-user procurement behaviors, and component-level design trade-offs

Understanding product-type distinctions and their downstream implications is essential for aligning capabilities with experimental needs. Bioluminescence imaging and fluorescence imaging constitute the principal modality families, with bioluminescence subdivided into spectral bioluminescence and standard bioluminescence; the former enables spectral unmixing of multiple reporters for multiplexed assays while the latter remains a workhorse for high-sensitivity single-reporter studies. Fluorescence imaging encompasses emerging fluorescence techniques, multispectral fluorescence systems, and near-infrared fluorescence modalities, each offering distinct trade-offs between depth penetration, signal-to-noise characteristics, and probe availability. These modality choices directly influence instrument configuration, probe selection, and downstream analysis pipelines.

Application-driven segmentation reveals differentiated demand patterns across cardiovascular research, drug discovery, neuroscience, and oncology. Cardiovascular studies span ischemia investigations and vessel imaging, where temporal resolution and vascular contrast are priorities. Drug discovery workflows emphasize pharmacokinetics and target validation, often requiring quantitative repeatability and validated probe kinetics. Neuroscience workstreams include neurodegenerative imaging and neuroinflammation imaging, both of which rely on careful consideration of blood-brain barrier dynamics and long-term monitoring capabilities. Oncology research spans metastasis monitoring, therapy response assessment, and tumor detection, with tumor detection further separated into early tumor detection and late-stage tumor detection; these applications necessitate a balance of sensitivity, resolution, and translationally relevant biomarkers.

End-user segmentation highlights how adoption patterns map to organizational capability and procurement practices. Academic and research institutes prioritize flexibility, methodological breadth, and training support, while contract research organizations emphasize throughput, standardized protocols, and validated deliverables. Pharmaceutical and biotechnology companies value integration with their internal data ecosystems, stringent validation pathways, and vendor stability. Component-level segmentation-consumables, hardware, services, and software-exposes additional decision levers: consumables such as imaging probes and reagents drive recurring revenue dynamics and require supply reliability; hardware components including imaging detectors, light sources, and optics determine baseline performance and upgrade paths, with detectors splitting into photon multiplier tubes and solid-state detectors and light sources differentiating between laser diodes and LED arrays; services ranging from consulting and training to installation and maintenance provide differentiation and lower adoption friction; and software offerings, spanning data management and image analysis, increasingly bifurcate into cloud-based platforms and on-premise solutions to accommodate diverse data governance and scalability needs.

Regionally specific dynamics that determine adoption patterns, procurement preferences, and supply-chain strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics materially shape demand patterns, regulatory constraints, and supply-chain resilience, and these effects vary meaningfully across geographies. In the Americas, strong translational research programs, concentrated pharmaceutical investment, and well-funded academic centers foster early adoption of advanced imaging modalities and support demand for integrated hardware-software-service bundles. This region also sees prioritized spending on longitudinal studies and CRO partnerships that require high-throughput, validated platforms. Europe, Middle East & Africa exhibits heterogeneity driven by robust research hubs in Western Europe, emerging clusters across the Middle East, and variable funding landscapes in other locales; regulatory frameworks and collaborative pan-European initiatives influence standardization and inter-institutional data sharing, increasing demand for interoperable systems and cloud-enabled data management that respect regional privacy regimes. In Asia-Pacific, rapid expansion of life sciences R&D, significant public and private investment in translational infrastructure, and an active manufacturing base create simultaneous pressure for competitive pricing and rapid innovation cycles. Collectively, these regional currents necessitate differentiated commercial strategies that align product configuration, pricing models, and service offerings with local procurement norms and regulatory contexts.

How technological differentiation, integrated service models, and resilient supply-chain strategies shape competitive advantage and customer retention dynamics

Competitive positioning in the in vivo imaging space is determined by a blend of technological leadership, service ecosystems, and channel capabilities. Successful firms differentiate through demonstrable performance in detector sensitivity, optical versatility, and software analytics, and they increasingly bundle installation, validation, and training services to lower customer adoption friction. Strategic partnerships with reagent and probe developers create mutual reinforcement between hardware sales and consumable adoption, helping to lock in recurring revenue streams. Companies that invest in modular architectures and firmware- or software-driven feature releases preserve upgrade pathways for customers and extend useful equipment lifecycles, which is a compelling commercial narrative in institutions with constrained capital budgets.

Go-to-market models are also evolving: direct sales supported by localized service teams remain essential for high-complexity equipment, while channel partnerships and CRO integrations expand reach for standardized workflows. Licensing arrangements or cloud-enabled analytics platforms create additional monetization vectors for companies that can demonstrate validated algorithms and regulatory-compliant data handling. Finally, manufacturing footprint and supply-chain resilience are competitive differentiators in a traded-components environment; firms with diversified sourcing and the ability to localize critical subassemblies reduce exposure to tariff volatility and delivery disruptions, thereby improving service-level commitments to major institutional buyers.

Actionable strategic measures for vendors and institutional buyers to enhance platform longevity, unlock recurring revenue, and fortify supply-chain resilience in imaging systems

Industry leaders should prioritize modularity and upgradeability in platform design to align with the rising preference for capital-efficient acquisition models. By enabling field-upgradeable detector and illumination modules, vendors can preserve customer relationships across multi-year research programs without forcing premature capital replacement. Simultaneously, investing in validated software pipelines that automate image preprocessing, spectral unmixing, and longitudinal biomarker extraction will increase the value of hardware sales and open recurring revenue opportunities through subscriptions or licensing arrangements. These software investments must emphasize interoperability and compliance with institutional data governance policies to facilitate adoption across diverse end users.

On the supply-chain front, companies should pursue diversified sourcing strategies that include nearshoring critical optical and detector components, strategic inventory buffers for high-risk parts, and collaborative forecasting with key suppliers. Developing certified consumable ecosystems through partnerships with probe manufacturers secures recurring streams and improves experimental reproducibility for end users. From a commercial perspective, packaging flexible procurement options-such as instrument-as-a-service, multi-year maintenance contracts, and bundled training-reduces friction for cash-constrained research organizations. Finally, establish structured collaborations with academic consortia and CROs to co-develop validated protocols and generate application-specific evidence that shortens buyer evaluation cycles and enhances trust in performance claims.

A rigorous mixed-methods research approach combining expert interviews, technical literature synthesis, supply-chain mapping, and scenario validation to ensure robust insights

The research underpinning this report integrates qualitative and quantitative methods to ensure a robust and reproducible evidence base. Primary research involved structured interviews with instrument engineers, procurement leads at academic and industry labs, and heads of imaging cores at contract research organizations to capture operational pain points, upgrade rationales, and service expectations. Secondary research synthesized peer-reviewed literature on imaging modalities, patent filing trends for detectors and probes, and publicly available technical specifications to map capability differentials. Supply-chain mapping identified critical upstream suppliers for detectors, light sources, and optical assemblies, and cross-validated these findings with import-export data and manufacturing footprint assessments.

Analytical approaches included component-level decomposition to reveal cost and risk drivers, scenario analysis to assess tariff and supply disruptions, and validation workshops with subject-matter experts to stress-test assumptions. Wherever possible, findings were triangulated across multiple data sources and stakeholder perspectives to reduce single-source bias. The methodology acknowledges limitations, including potential variability in regional procurement practices and ongoing technical innovations that may alter component availability; therefore, recommendations are framed to be adaptive and to encourage periodic re-evaluation as new data emerge.

Synthesis of technological, commercial, and operational imperatives that together determine which organizations will successfully translate imaging capability into scientific and business outcomes

In vivo imaging systems are at an inflection point where instrument sensitivity, probe chemistry, and computational analytics converge to expand experimental possibilities and accelerate translational research. Stakeholders across academia, CROs, and industry face overlapping pressures: the need to maintain high data quality and reproducibility, to manage capital and operational costs amid supply-chain uncertainty, and to extract greater value from integrated hardware-software-service offerings. Navigating these pressures requires product strategies that emphasize modularity, validated software ecosystems that enable reproducible analytics, and supply chains engineered for resilience.

Looking ahead, the organizations that will succeed are those that align technical innovation with pragmatic commercial models-those that offer upgradeable platforms, secure access to validated consumables, and service bundles that reduce adoption friction. By prioritizing interoperability, regulatory-aware data management, and partnerships that drive protocol standardization, both vendors and end users can convert technological progress into tangible improvements in study throughput and translational impact. This conclusion frames the actionable imperatives detailed throughout the report and underscores the value of acquiring the full analysis to inform procurement, R&D, and partnership decisions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. IVIS Imaging Systems Market, by Product Type

  • 8.1. Bioluminescence Imaging
    • 8.1.1. Spectral Bioluminescence
    • 8.1.2. Standard Bioluminescence
  • 8.2. Fluorescence Imaging

9. IVIS Imaging Systems Market, by Component

  • 9.1. Consumables
    • 9.1.1. Imaging Probes
    • 9.1.2. Reagents
  • 9.2. Hardware
    • 9.2.1. Imaging Detectors
      • 9.2.1.1. Photon Multiplier Tubes
      • 9.2.1.2. Solid State Detectors
    • 9.2.2. Light Sources
      • 9.2.2.1. Laser Diodes
      • 9.2.2.2. Led Arrays
    • 9.2.3. Optics
  • 9.3. Services
    • 9.3.1. Consulting And Training
    • 9.3.2. Installation And Maintenance
  • 9.4. Software
    • 9.4.1. Data Management Software
    • 9.4.2. Image Analysis Software

10. IVIS Imaging Systems Market, by Application

  • 10.1. Cardiovascular Research
    • 10.1.1. Ischemia Studies
    • 10.1.2. Vessel Imaging
  • 10.2. Drug Discovery
    • 10.2.1. Pharmacokinetics
    • 10.2.2. Target Validation
  • 10.3. Neuroscience
    • 10.3.1. Neurodegenerative Imaging
    • 10.3.2. Neuroinflammation Imaging
  • 10.4. Oncology
    • 10.4.1. Metastasis Monitoring
    • 10.4.2. Therapy Response Assessment
    • 10.4.3. Tumor Detection
      • 10.4.3.1. Early Tumor Detection
      • 10.4.3.2. Late Stage Tumor Detection

11. IVIS Imaging Systems Market, by End User

  • 11.1. Academic And Research Institutes
  • 11.2. Contract Research Organizations
  • 11.3. Pharmaceutical And Biotechnology Companies

12. IVIS Imaging Systems Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. IVIS Imaging Systems Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. IVIS Imaging Systems Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States IVIS Imaging Systems Market

16. China IVIS Imaging Systems Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agilent Technologies
  • 17.6. Analytik Jena AG
  • 17.7. Berthold Technologies GmbH & Co. KG
  • 17.8. BioTek Instruments, Inc.
  • 17.9. Bruker Corporation
  • 17.10. Caliper Life Sciences
  • 17.11. Canon Medical Systems Corporation
  • 17.12. Carestream Health, Inc.
  • 17.13. Fujifilm Holdings Corporation
  • 17.14. GE Healthcare
  • 17.15. Hitachi Medical Corporation
  • 17.16. LI-COR Biosciences
  • 17.17. Miltenyi Biotec
  • 17.18. Molecular Devices, LLC
  • 17.19. Olympus Corporation
  • 17.20. PerkinElmer Inc.
  • 17.21. Promega Corporation
  • 17.22. Siemens Healthineers
  • 17.23. Spectral Instruments Imaging
  • 17.24. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IVIS IMAGING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL IVIS IMAGING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES IVIS IMAGING SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA IVIS IMAGING SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY BIOLUMINESCENCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY BIOLUMINESCENCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY BIOLUMINESCENCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY BIOLUMINESCENCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY SPECTRAL BIOLUMINESCENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY SPECTRAL BIOLUMINESCENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY SPECTRAL BIOLUMINESCENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY STANDARD BIOLUMINESCENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY STANDARD BIOLUMINESCENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY STANDARD BIOLUMINESCENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY FLUORESCENCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY FLUORESCENCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY FLUORESCENCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY PHOTON MULTIPLIER TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY PHOTON MULTIPLIER TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY PHOTON MULTIPLIER TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY SOLID STATE DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY SOLID STATE DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY SOLID STATE DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY LIGHT SOURCES, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY LASER DIODES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY LASER DIODES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY LASER DIODES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY LED ARRAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY LED ARRAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY LED ARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY OPTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY OPTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY OPTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSULTING AND TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSULTING AND TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSULTING AND TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY INSTALLATION AND MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY INSTALLATION AND MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY INSTALLATION AND MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY ISCHEMIA STUDIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY ISCHEMIA STUDIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY ISCHEMIA STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY VESSEL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY VESSEL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY VESSEL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY PHARMACOKINETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY PHARMACOKINETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY PHARMACOKINETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY TARGET VALIDATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY TARGET VALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROSCIENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROSCIENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROSCIENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY NEURODEGENERATIVE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY NEURODEGENERATIVE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY NEURODEGENERATIVE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROINFLAMMATION IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROINFLAMMATION IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROINFLAMMATION IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY METASTASIS MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY METASTASIS MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY METASTASIS MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY THERAPY RESPONSE ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY THERAPY RESPONSE ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY THERAPY RESPONSE ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY TUMOR DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY TUMOR DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY TUMOR DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY TUMOR DETECTION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY EARLY TUMOR DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY EARLY TUMOR DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY EARLY TUMOR DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY LATE STAGE TUMOR DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY LATE STAGE TUMOR DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY LATE STAGE TUMOR DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY BIOLUMINESCENCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY LIGHT SOURCES, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY TUMOR DETECTION, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS IVIS IMAGING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY BIOLUMINESCENCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY LIGHT SOURCES, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY TUMOR DETECTION, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY BIOLUMINESCENCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY LIGHT SOURCES, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY TUMOR DETECTION, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA IVIS IMAGING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY BIOLUMINESCENCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY LIGHT SOURCES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY TUMOR DETECTION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY BIOLUMINESCENCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY LIGHT SOURCES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY TUMOR DETECTION, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE IVIS IMAGING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY BIOLUMINESCENCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY LIGHT SOURCES, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY TUMOR DETECTION, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST IVIS IMAGING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY BIOLUMINESCENCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY LIGHT SOURCES, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY TUMOR DETECTION, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA IVIS IMAGING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY BIOLUMINESCENCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY LIGHT SOURCES, 2018-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY TUMOR DETECTION, 2018-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC IVIS IMAGING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. GLOBAL IVIS IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY BIOLUMINESCENCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY LIGHT SOURCES, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY TUMOR DETECTION, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN IVIS IMAGING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 291. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY BIOLUMINESCENCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 293. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 294. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 295. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 296. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 297. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY LIGHT SOURCES, 2018-2032 (USD MILLION)
  • TABLE 298. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 299. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 300. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 301. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 302. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 303. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
  • TABLE 304. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 305. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY TUMOR DETECTION, 2018-2032 (USD MILLION)
  • TABLE 306. GCC IVIS IMAGING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION IVIS IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 308. EUROPEAN UNION IVIS IMAGING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION IVIS IMAGING SYSTEMS MARKET SIZE, BY BIOLUMINESCENCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPEAN UNION IVIS IMAGING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION IVIS IMAGING SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPEAN UNION IVIS IMAGING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION IVIS IMAGING SYSTEMS MARKET SIZE, BY IMAGING DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION IVIS IMAGING SYSTEMS MARKET SIZE, BY LIGHT SOURCES, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION IVIS IMAGING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPEAN UNION IVIS IMAGING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION IVIS IMAGING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 318. EUROPEAN UNION IVIS IMAGING SYSTEMS MARKET SIZE, BY CARDIOVASCULAR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION IVIS IMAGING SYSTEMS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 320. EUROPEAN UNION IVIS IMAGING SYSTEMS MARKET SIZE, BY NEUROSCIENCE, 2018-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION IVIS IMAGING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 322. EUROPEAN UNION IVIS IMAGIN